Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk

Int J Mol Sci. 2021 Nov 17;22(22):12380. doi: 10.3390/ijms222212380.

Abstract

Cardiovascular disease is strongly influenced by platelet activation. Platelet activation and thrombus formation at atherosclerotic plaque rupture sites is a dynamic process regulated by different signaling networks. Therefore, there are now focused efforts to search for novel bioactive compounds which target receptors and pathways in the platelet activation process while preserving normal hemostatic function. The antiplatelet activity of numerous fruits and vegetables and their multiple mechanisms of action have recently been highlighted. In this review, we review the antiplatelet actions of bioactive compounds via key pathways (protein disulfide isomerase, mitogen-activated protein kinases, mitochondrial function, cyclic adenosine monophosphate, Akt, and shear stress-induced platelet aggregation) with no effects on bleeding time. Therefore, targeting these pathways might lead to the development of effective antiplatelet strategies that do not increase the risk of bleeding.

Keywords: bioactive compounds; bleeding; hemostasis; platelet; thrombosis.

Publication types

  • Review

MeSH terms

  • Animals
  • Blood Platelets / drug effects
  • Blood Platelets / metabolism*
  • Hemorrhage / metabolism
  • Hemorrhage / prevention & control*
  • Hemostasis / drug effects
  • Humans
  • Phytochemicals / pharmacology
  • Phytochemicals / therapeutic use*
  • Plaque, Atherosclerotic / metabolism
  • Platelet Activation / drug effects*
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / pharmacology
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Thrombosis / drug therapy*
  • Thrombosis / metabolism

Substances

  • Phytochemicals
  • Platelet Aggregation Inhibitors